Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Predictive biomarker for hypoxia-activated prodrug therapy

Predictive biomarker for hypoxia-activated prodrug therapy

US Patent 10760130 · Granted Sep 1, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating cancer with farnesyltransferase inhibitors2023
Methods of treating cancer with farnesyltransferase inhibitors2022
Methods of treating cancer patients with farnesyltransferase inhibitors2021
Methods of treating cancer patients with farnesyltransferase inhibitors2021
Methods of treating cancer with farnesyltransferase inhibitors2021
Methods of treating cancer with farnesyltransferase inhibitors2020
Methods of treating cancer patients with farnesyltransferase inhibitors2019
Methods of treating cancer with farnesyltransferase inhibitors2019
Methods of treating cancer patients with farnesyltransferase inhibitors2019
Methods of treating cancer patients with farnesyltransferase inhibitors2019
Methods of treating cancer with farnesyltransferase inhibitors2018
Predictive biomarker for hypoxia-activated prodrug therapy2018